• Home
    • StockRanks™
    • Platform
        • Research & Discuss
        • Editorial & Community
        • Learn & Improve
        • Webinars & Masterclasses
        • Stockopedia Academy
    • Reviews
    • Pricing
    Get startedLog in
    SectorsHealthcareBiotechnology & Medical ResearchCartesian Therapeutics
    Picture of Cartesian Therapeutics logo

    RNAC — Cartesian Therapeutics News Story

    $6.180.000.00%
    us flag iconLast trade - 00:00
    HealthcareSpeculativeSmall CapMomentum Trap
    • Market Cap
      $186.98m
    • Enterprise Value
      $92.22m
    • Revenue
      $2.80m
    • Quality
    • Value
    • Momentum
    • StockRank™
    • StockReport™
    • Accounts
      • Balance sheet
      • Income statement
      • Cashflow statement
      • Dividend summary
    • News
    • RNAC Dividends
    StockReport™
    Balance sheet
    Income statement
    Cashflow
    News
    RNAC Dividends
    All News

    NASDAQ RESUMED AT 09:40 AM

    Picture of Cartesian Therapeutics logoCartesian Therapeutics
    09/06/2026 14:40
    NASDAQ RESUMED  AT 09:40 AM

    Recent news on Cartesian Therapeutics

    See all news
    • Brief: Cartesian Therapeutics Announces Additional Retreatment Data For Descartes-08 Highlighting Deep And Durable Responses In Patients With Myasthenia Gravis

      29/09/2026 12:31
    • Cartesian Therapeutics, Inc. reports results for the quarter ended June 30 - Earnings Summary

      06/08/2026 14:02
    • Cartesian Therapeutics Q2 net income steady

      06/08/2026 12:44
    • Brief: Cartesian Therapeutics Inc Q2 Net Income USD 15.769 Million

      06/08/2026 12:01
    • Cartesian Therapeutics Inc expected to post a loss of 87 cents a share - Earnings Preview

      03/08/2026 13:42

    Company

    • About us
    • Careers
    • Product Guide

    Our Coverage

    • Countries
    • Sectors
    • Ratios

    Top Stocks

    • UK Stocks
    • Australian Stocks
    • US Stocks

    Legals

    • Privacy Policy
    • Terms & Conditions
    • Disclaimer & FSG
    • Cookies
    Trustpilot
    Select a country/region:


    © Stockopedia 2026, Refinitiv, Share Data Services.

    *Past performance is no indicator of future performance, and testimonials are provided by third parties for informational purposes only and are not intended and should not be taken to be financial product advice. Performance returns are based on hypothetical scenarios and do not represent an actual investment.

    This site cannot substitute for professional investment advice or independent factual verification. To use Stockopedia, you must accept our Terms of use, Privacy and Disclaimer & FSG. All services are provided by Stockopedia Ltd, United Kingdom (company number 06367267). For Australian users: Stockopedia Ltd, ABN 39 757 874 670 is a Corporate Authorised Representative of Daylight Financial Group Pty Ltd ABN 77 633 984 773, AFSL 521404.